128 related articles for article (PubMed ID: 21205951)
21. Efficacy of intralesional methotrexate in specific cutaneous involvement of B-cell chronic lymphocytic leukaemia.
Anyfantakis V; Dammak A; Wierzbicka-Hainaut E; Camus M; Osdoit S; Levilain P; Guillet G
J Eur Acad Dermatol Venereol; 2010 Jul; 24(7):856. PubMed ID: 19943835
[No Abstract] [Full Text] [Related]
22. Systemic anaphylactic reaction following intrathecal administration of methotrexate in adult patient with primary central nervous system lymphoma.
Elkiran ET; Altundag K; Aksoy S; Onal IK; Tekuzman G
Am J Hematol; 2004 Apr; 75(4):265. PubMed ID: 15054831
[No Abstract] [Full Text] [Related]
23. Intrathecal methotrexate-induced acute cerebellar syndrome.
Ferhanoglu B; Ongören S; Ar CM; Uzel B; Forta H; Necioglu D
Ann Hematol; 2003 Apr; 82(4):241-3. PubMed ID: 12707728
[TBL] [Abstract][Full Text] [Related]
24. [Managing methotrexate toxicity: a case report].
Fernández Megía MJ; Alós Almiñana M; Terol Castera MJ
Farm Hosp; 2004; 28(5):371-4. PubMed ID: 15504095
[TBL] [Abstract][Full Text] [Related]
25. Ultraviolet recall reaction after total body irradiation, etoposide, and methotrexate therapy.
Goldfeder KL; Levin JM; Katz KA; Clarke LE; Loren AW; James WD
J Am Acad Dermatol; 2007 Mar; 56(3):494-9. PubMed ID: 17187896
[TBL] [Abstract][Full Text] [Related]
26. [Primary central nervous system lymphoma: diagnosis, management and current topics].
Arita N
No To Shinkei; 2004 Mar; 56(3):195-203. PubMed ID: 15112444
[No Abstract] [Full Text] [Related]
27. Impact of the methotrexate administration dose on the need for intrathecal treatment in children and adolescents with anaplastic large-cell lymphoma: results of a randomized trial of the EICNHL Group.
Brugières L; Le Deley MC; Rosolen A; Williams D; Horibe K; Wrobel G; Mann G; Zsiros J; Uyttebroeck A; Marky I; Lamant L; Reiter A
J Clin Oncol; 2009 Feb; 27(6):897-903. PubMed ID: 19139435
[TBL] [Abstract][Full Text] [Related]
28. Intravitreal methotrexate for retinoblastoma.
Kivelä T; Eskelin S; Paloheimo M
Ophthalmology; 2011 Aug; 118(8):1689, 1689.e1-6. PubMed ID: 21813093
[No Abstract] [Full Text] [Related]
29. Neoplastic lymphomatous submaculopathy.
Testi I; Agarwal A; Gupta V;
Indian J Ophthalmol; 2019 Dec; 67(12):2051-2052. PubMed ID: 31755451
[No Abstract] [Full Text] [Related]
30. Methotrexate therapy for ocular cicatricial pemphigoid.
McCluskey P; Chang JH; Singh R; Wakefield D
Ophthalmology; 2004 Apr; 111(4):796-801. PubMed ID: 15051215
[TBL] [Abstract][Full Text] [Related]
31. Intravenous high-dose methotrexate based systemic therapy in the treatment of isolated primary vitreoretinal lymphoma: An LOC network study.
Lam M; Touitou V; Choquet S; Cassoux N; Ghesquières H; Kodjikian L; Schmitt A; Gattoussi S; Tabouret É; Sampo M; Blonski M; Angioi-Duprez K; Houot R; Mouriaux F; Gyan E; Le Lez ML; Moles MP; Croisé F; Chauchet A; Schwartz C; Ahle G; Meyer L; Gressin R; Chiquet C; Oberic L; Ollé P; Marolleau JP; Jany B; Tempescul A; Cochener B; Damaj G; Quintyn JC; Moluçon-Chabrot C; Rousseau E; Franciane P; Schneider C; Massé H; Tamburini-Bonnefoy J; Brézin A; Fornecker LM; Ballonzoli L; Le Garff-Tavernier M; Hoang-Xuan K; Bodaghi B; Soussain C; Houillier C
Am J Hematol; 2021 Jul; 96(7):823-833. PubMed ID: 33864703
[TBL] [Abstract][Full Text] [Related]
32. Polyuria associated with high-dose methotrexate in two patients with acute lymphoblastic leukaemia.
Lau KK; Weiss AR; Jones DP
J Oncol Pharm Pract; 2005 Mar; 11(1):31-3. PubMed ID: 16460601
[TBL] [Abstract][Full Text] [Related]
33. Methotrexate-induced primary cutaneous diffuse large B-cell lymphoma with an 'angiocentric' histological morphology.
Pfistershammer K; Petzelbauer P; Stingl G; Mastan P; Chott A; Jäger U; Skrabs C; Geusau A
Clin Exp Dermatol; 2010 Jan; 35(1):59-62. PubMed ID: 19486063
[TBL] [Abstract][Full Text] [Related]
34. Resumption of high-dose methotrexate after methotrexate-induced nephrotoxicity and carboxypeptidase G2 use.
Snyder RL
Am J Health Syst Pharm; 2007 Jun; 64(11):1163-9. PubMed ID: 17519458
[TBL] [Abstract][Full Text] [Related]
35. Primary central nervous system lymphoma: long-term survival following treatment with radiation and methotrexate.
Petursson SR
Eur J Surg Oncol; 1989 Feb; 15(1):69-72. PubMed ID: 2645176
[TBL] [Abstract][Full Text] [Related]
36. Atypical methotrexate-induced ultraviolet recall phenomenon during the treatment of ectopic pregnancy.
Wackowski J; English JC
J Am Acad Dermatol; 2010 Jul; 63(1):e10-1. PubMed ID: 20542166
[No Abstract] [Full Text] [Related]
37. [Cardiac infiltration as complication of cutaneous T-lymphoblastic non-Hodgkin's lymphoma].
Opherk JP; Lotz J; Galanski M
Rofo; 2007 Feb; 179(2):175-6. PubMed ID: 17199184
[No Abstract] [Full Text] [Related]
38. Severe complications after intrathecal methotrexate (MTX) for treatment of primary central nervous system lymphoma (PCNSL).
Weigel R; Senn P; Weis J; Krauss JK
Clin Neurol Neurosurg; 2004 Mar; 106(2):82-7. PubMed ID: 15003295
[TBL] [Abstract][Full Text] [Related]
39. [Management recommendations in patients with methotrexate intoxication].
Schellens JH; Beijnen JH
Ned Tijdschr Geneeskd; 2007 Feb; 151(6):337-41. PubMed ID: 17352296
[TBL] [Abstract][Full Text] [Related]
40. Methotrexate-induced radiation recall.
Camidge DR
Am J Clin Oncol; 2001 Apr; 24(2):211-3. PubMed ID: 11319302
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
